A $1 billion effort by the Obama administration to relieve the physician shortage in rural America by subsidizing med school debt for young physicians is running up against a problem--not in attracting docs in the first place, but keeping them there once their initial three-to-five-year commitment is up.
Highlights of the important and the interesting from the world of healthcare: Medicare: Solvent until 2029? The annual report from Medicare’s trustees says the program has enough money to be solvent until 2029–an improvement of 12 years over last year’s report–thanks mainly to savings contained in this year’s controversial health reform law. Sounds good, but […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Highlights of the important and the interesting from the world of healthcare: iPhone or Android: Which is better for doctors? The answer, according to Jeff Brandt, president of Communication Software, appears to be “both.” While that may be a bit unsatisfying, Brandt says that the Android–since it’s an operating system used in numerous types of […]
Highlights of the important and the interesting from the world of healthcare: Another lackluster biotech IPO: Although shares of Trius Therapeutics closed flat on the anti-infective drug developer’s first day of trading, no matter what happened the company’s public debut has to be considered a disappointment. After hoping for a price of $12 to $14 […]
Highlights of the important and the interesting from the world of healthcare: Is Genzyme on the block? A report that GlaxoSmithKline “casually requested” that Genzyme let it know if the latter ever puts itself up for sale has created a bit of a buzz, even if it’s unlikely GSK would be interested in pulling the […]
Highlights of the important and the interesting from the world of healthcare: The end of health insurance M&A? Maybe not the end, but clearing regulatory hurdles likely will become much more difficult. The Justice Department is looking to step up antitrust enforcement of health insurance mergers, because much of the health reform law’s success depends […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Highlights of the important and the interesting from the world of healthcare: A green day for VCs: In what’s believed to be the first deal of its kind, Trilogy Partners and a group of Colorado-based angel investors are providing a $2 million first funding round to a company that provides classes and certification about medical […]
Attention Minnesota: the Food and Drug Administration wants your orphans. In August, the University of Minnesota will host a FDA workshop where the agency will help area researchers, biotech firms and drug companies apply for “orphan drug” status, a fast-track approval program for drugs that treat rare diseases like Huntington’s disease, myoclonus, ALS (Lou Gehrig’s […]